Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ann Surg Oncol ; 31(9): 5757-5764, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38869765

ABSTRACT

BACKGROUND: Underrepresented minority patients with surgical malignancies experience disparities in outcomes. The impact of provider-based factors, including communication, trust, and cultural competency, on outcomes is not well understood. This study examines modifiable provider-based barriers to care experienced by patients with surgical malignancies. METHODS: A parallel, prospective, mixed-methods study enrolled patients with lung or gastrointestinal malignancies undergoing surgical consultation. Surveys assessed patients' social needs and patient-physician relationship. Semi-structured interviews ascertained patient experiences and were iteratively analyzed, identifying key themes. RESULTS: The cohort included 24 patients (age 62 years; 63% White and 38% Black/African American). The most common cancers were lung (n = 18, 75%) and gastroesophageal (n = 3, 13%). Survey results indicated that food insecurity (n = 5, 21%), lack of reliable transportation (n = 4, 17%), and housing instability (n = 2, 8%) were common. Lack of trust in their physician (n = 3, 13%) and their physician's treatment recommendation (n = 3, 13%) were identified. Patients reported a lack of empathy (n = 3, 13%), lack of cultural competence (n = 3, 13%), and inadequate communication (n = 2, 8%) from physicians. Qualitative analysis identified five major themes regarding the decision to undergo surgery: communication, trust, health literacy, patient fears, and decision-making strategies. Five patients (21%) declined the recommended surgery and were more likely Black (100% vs. 21%), lower income (100% vs. 16%), and reported poor patient-physician relationship (40% vs. 5%; all p < 0.05). CONCLUSIONS: Factors associated with declining recommended cancer surgery were underrepresented minority race and poor patient-physician relationships. Interventions are needed to improve these barriers to care and racial disparities.


Subject(s)
Decision Making , Healthcare Disparities , Physician-Patient Relations , Trust , Humans , Prospective Studies , Middle Aged , Male , Female , Aged , Black or African American/statistics & numerical data , Black or African American/psychology , Prognosis , Gastrointestinal Neoplasms/surgery , Lung Neoplasms/surgery , Follow-Up Studies , Cultural Competency , Communication , White People/statistics & numerical data , Minority Groups/statistics & numerical data , Adult
2.
J Relig Health ; 59(5): 2611-2622, 2020 Oct.
Article in English | MEDLINE | ID: mdl-30706200

ABSTRACT

This study examined whether age plays a role in the relationship between religiosity and adolescent major depressive episodes (MDEs). The 2012 National Survey on Drug Use and Health data was examined. Odds ratios were computed to determine if the association between religiosity and MDE differed based on age of adolescent among 12-13-year-olds, 14-15-year-olds, and 16-17-year-olds. Results indicated that 9.7% of adolescents reported having an MDE within the past year. Past-year MDE did not differ based on religious attendance for any of the three age groups. However, 12-13- and 14-15-year-olds who did not feel their religious beliefs influence how they make decisions in their life were at increased risk for a past-year MDE. For 15-16-year-olds and 16-17-year-olds, those who did not feel it was important that their friends share their religious beliefs were at increased risk for a past-year MDE. Such findings appear to indicate that certain aspects of religiosity may provide a significant protective effect against adolescent MDE. Prevention professionals and health educators should consider these findings to help bolster ongoing and future MDE prevention efforts. Recommendations for future research are provided.


Subject(s)
Depressive Disorder, Major , Adolescent , Child , Humans , Longitudinal Studies , Religion , Substance-Related Disorders
4.
Cancer Prev Res (Phila) ; 16(10): 545-547, 2023 10 02.
Article in English | MEDLINE | ID: mdl-37779459

ABSTRACT

The incidence of second primary cancers is rising particularly among pediatric, adolescent, and young adult (PAYA) cancer survivors. While human papillomavirus (HPV)-associated cancers can be prevented by vaccination, their uptake is lower and delayed in this group. Because a recommendation from a health care provider is the strongest predictor of HPV vaccination, there are great opportunities for PAYA cancer care providers to positively impact HPV vaccination rates. Prioritizing PAYA cancer care provider education as well as improving the education of and coordination with primary care providers are viewed as opportunities to encourage HPV vaccine uptake and prevent future cancers. See related article by Garcia et al., p. 581.


Subject(s)
Cancer Survivors , Neoplasms , Papillomavirus Infections , Papillomavirus Vaccines , Humans , Child , Adolescent , Young Adult , Human Papillomavirus Viruses , Papillomavirus Vaccines/therapeutic use , Papillomavirus Infections/complications , Papillomavirus Infections/prevention & control , Papillomavirus Infections/epidemiology , Vaccination , Neoplasms/epidemiology , Neoplasms/prevention & control , Primary Health Care
5.
J Child Adolesc Psychopharmacol ; 30(6): 376-380, 2020 07.
Article in English | MEDLINE | ID: mdl-32423240

ABSTRACT

Objectives: The objective of this research was to understand physician, patient, and parent perspectives on barriers to second-generation antipsychotic (SGA) medication adherence in youth with bipolar spectrum disorders, and attitudes toward treatment of SGA-related weight gain. Methods: Patients diagnosed with bipolar disorder before age 18, parents of children diagnosed before 18, and clinicians with experience prescribing SGAs for these patients completed surveys regarding SGA-related side effects, adherence barriers, and acceptability of weight management strategies. Results: Patients (n = 225), parents (n = 128), and clinicians (n = 54) reported weight gain as the most concerning SGA-related side effect (45.6%, 38.9%, and 70.4%, respectively). Weight gain was also the top adherence barrier for patients (35.9%), but was ranked fourth (41.8%) by parents. Patients (61.5%) were more likely "definitely" willing to co-initiate another medication to manage weight gain upon SGA initiation than parents (20.1%) or clinicians (1.9%). Conversely, parents (54.9%) and clinicians (84.9%) were "definitely" willing to accept/prescribe a second medication aiming to reverse weight gain of ≥10 lbs., and patients (61.1%) were willing to add another medication to reverse any weight gain. Conclusion: SGA-related weight gain impairs medication adherence in young patients with bipolar disorder. Many young patients would start pharmacologic treatment to mitigate SGA-related weight gain at treatment initiation, parents and clinicians are more hesitant. This research informs patient-centered perspectives on SGA adherence barriers and strategies to minimize potential side effects, which may improve adherence in this vulnerable patient population.


Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Health Personnel , Medication Adherence , Parents/psychology , Patients , Weight Gain/drug effects , Adolescent , Attitude to Health , Child , Female , Health Personnel/psychology , Health Personnel/statistics & numerical data , Humans , Internet , Male , Patients/psychology , Patients/statistics & numerical data , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL